Pennant ROE 2018-2026 | PNTG
Current and historical return on equity (ROE) values for Pennant (PNTG) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Pennant ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-03-31 | $0.03B | $0.36B | 8.61% |
| 2025-12-31 | $0.03B | $0.34B | 8.73% |
| 2025-09-30 | $0.03B | $0.33B | 8.23% |
| 2025-06-30 | $0.03B | $0.29B | 9.34% |
| 2025-03-31 | $0.03B | $0.25B | 10.45% |
| 2024-12-31 | $0.02B | $0.21B | 11.00% |
| 2024-09-30 | $0.02B | $0.17B | 12.54% |
| 2024-06-30 | $0.02B | $0.16B | 12.20% |
| 2024-03-31 | $0.02B | $0.15B | 10.96% |
| 2023-12-31 | $0.01B | $0.14B | 9.47% |
| 2023-09-30 | $0.01B | $0.13B | 9.07% |
| 2023-06-30 | $0.01B | $0.13B | 10.20% |
| 2023-03-31 | $0.01B | $0.12B | 5.67% |
| 2022-12-31 | $0.01B | $0.12B | 4.97% |
| 2022-09-30 | $0.00B | $0.12B | 0.85% |
| 2022-06-30 | $0.00B | $0.12B | -2.59% |
| 2022-03-31 | $0.00B | $0.11B | 2.63% |
| 2021-12-31 | $0.00B | $0.11B | 2.71% |
| 2021-09-30 | $0.01B | $0.11B | 8.37% |
| 2021-06-30 | $0.01B | $0.10B | 11.85% |
| 2021-03-31 | $0.01B | $0.10B | 13.76% |
| 2020-12-31 | $0.02B | $0.09B | 17.19% |
| 2020-09-30 | $0.01B | $0.08B | 8.78% |
| 2020-06-30 | $0.01B | $0.08B | 6.37% |
| 2020-03-31 | $0.00B | $0.06B | 6.93% |
| 2019-12-31 | $0.00B | $0.04B | 5.16% |
| 2019-06-30 | $0.01B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.072B | $0.948B |
| The Pennant Group Inc. through subsidiaries offers home health, hospice and senior living services. It operates primarily in Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The Pennant Group Inc. is based in Eagle, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |